ML-171 Attenuates Pentylenetetrazole-Associated Oxidative and Apoptotic Injury Without Robust Suppression of Seizure Expression: An In Vitro and In Vivo Study
International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6269
DOI: 10.3390/ijms27146269 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Ahmet Ozan Kaleci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey. Hauptthemen laut MEDLINE: Pentylenetetrazole, Apoptosis, Oxidative Stress, Seizures. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sivas Cumhuriyet Üniversitesi, Sivas Cumhuriyet University.
Abstract (Originalsprache)
Oxidative stress and apoptosis contribute to seizure-associated neuronal injury, but the effects of ML-171, a pharmacological NOX-1 inhibitor, on PTZ-associated oxidative and apoptotic injury remain insufficiently defined. This study evaluated the effects of the NOX-1 inhibitor ML-171 in pentylenetetrazole (PTZ)-induced cellular and animal models of neuronal injury. SH-SY5Y cells were exposed to PTZ (30 mM, 24 h) after pretreatment with ML-171 or valproic acid (VPA), and cell viability, redox status, apoptosis-related proteins, and Annexin V-based cell death were assessed. Adult male Wistar Albino rats were subjected to PTZ kindling and acutely treated with VPA or ML-171 (0.1, 1, or 10 mg/kg); behavioral seizures, electrocorticographic activity, hippocampal oxidative stress, apoptotic markers, histopathology, and NOX-1 immunoreactivity were evaluated. ML-171 attenuated PTZ-induced cellular injury in SH-SY5Y cells within a restricted concentration window and reduced oxidant burden, oxidative stress index, and apoptotic signaling. In PTZ-kindled rats, ML-171 improved hippocampal oxidative and apoptotic markers but did not robustly suppress behavioral or electrophysiological seizure parameters. Histopathological injury and NOX-1 immunoreactivity showed region- and dose-dependent responses. These findings suggest that ML-171 primarily attenuates PTZ-associated oxidative and apoptotic injury rather than exerting a conventional antiseizure effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey.
- Department of Physiology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey.
- Department of Veterinary Pathology, Faculty of Veterinary Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey.
ORCID-Profile: Ahmet Altun, Mustafa Özkaraca
Förderung
- Sivas Cumhuriyet Üniversitesi
- Sivas Cumhuriyet University
Zitieren
APA
Kaleci, A. O., Altun, A., Taşkıran, A. Ş., Özkaraca, M., & Bağçivan, İ. (2026). ML-171 Attenuates Pentylenetetrazole-Associated Oxidative and Apoptotic Injury Without Robust Suppression of Seizure Expression: An In Vitro and In Vivo Study. International Journal of Molecular Sciences, 27(14), 6269. https://doi.org/10.3390/ijms27146269
Vancouver
Kaleci AO, Altun A, Taşkıran AŞ, Özkaraca M, Bağçivan İ. ML-171 Attenuates Pentylenetetrazole-Associated Oxidative and Apoptotic Injury Without Robust Suppression of Seizure Expression: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. 2026;27(14):6269. doi:10.3390/ijms27146269
BibTeX
@article{Kaleci2026,
author = {Kaleci, Ahmet Ozan and Altun, Ahmet and Taşkıran, Ahmet Şevki and Özkaraca, Mustafa and Bağçivan, İhsan},
title = {ML-171 Attenuates Pentylenetetrazole-Associated Oxidative and Apoptotic Injury Without Robust Suppression of Seizure Expression: An In Vitro and In Vivo Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6269},
doi = {10.3390/ijms27146269}
}
EUVIMED